Truwin 4 mg Tablet (Silodosin)

Adult dose

Adults: Administer orally either 1 tablet of 4 mg per dose twice daily after breakfast and dinner, or 2 tablets of 4 mg (8 mg) once daily with a meal. However, increased plasma concentrations of silodosin have been reported in patients with renal impairment, and plasma concentrations may also increase in patients with hepatic impairment. Therefore, monitor the patient's condition and adjust the dose appropriately according to symptoms, such as starting at a low dose (2 mg per dose, twice daily).

This medication should not be used in certain patients. For instance, patients who are allergic to any of the ingredients of this medication or those with severely impaired kidney function, significantly reduced liver function, or who are taking certain powerful medications should not take this drug. Additionally, patients with symptoms of orthostatic hypotension or issues with liver and kidney function, and those taking various other medications should use this drug cautiously. While taking this medication, various side effects may occur. The most common side effects include ejaculation disorders, dry mouth, diarrhea, dizziness, nasal congestion, headaches, etc. In severe cases, syncope or liver dysfunction may occur, and if any abnormal symptoms arise, consultation with a doctor should be sought immediately. This medication can lower blood pressure; therefore, patients taking antihypertensive medications should carefully monitor changes in blood pressure, and adjustments may be necessary if blood pressure drops too low. During treatment, there is a risk of dizziness or syncope due to sudden changes in body position. It is advisable to move slowly when getting up. This medication is used for symptomatic relief rather than causal treatment; if ineffective, other treatment options such as surgery should be considered. Furthermore, it is crucial to confirm the absence of prostate cancer before taking this medication, and caution is required when co-administering with other alpha-blockers or PDE5 inhibitors. In older adults, liver and kidney functions may be impaired, so treatment should start at a low dose and closely monitored based on the patient's condition. This medication should be kept out of reach of children and should not be transferred to other containers. Lastly, while some abnormal findings have been reported in animal studies regarding the long-term use of this medication, the carcinogenic potential in humans has not been confirmed.

sexual dysfunction, dry mouth, diarrhea, loose stools, orthostatic dizziness, nasal congestion, dizziness, lightheadedness, headache, increased TG, increased CRP, increased ALT, increased AST, increased γ-GTP, syncope, loss of consciousness, liver dysfunction, jaundice, erectile dysfunction, urinary incontinence, stomatitis, gastric discomfort, constipation, vomiting, nausea, loss of appetite, gastric pain, abdominal pain, abdominal bloating, epigastric discomfort, lower abdominal pain, gastric ulcer, gastritis, atrophic gastritis, heartburn, gastric burning, duodenal ulcer, increased flatulence, increased bowel movements, incomplete evacuation sensation, anal discomfort, fatigue, shoulder stiffness, tingling in hands and feet, feeling of being dazed, drowsiness, decreased libido, heaviness in the head, mood disturbances, nosebleed, rhinorrhea, cough, edema, atrial fibrillation, bradycardia, tachycardia, arrhythmia, loss of escape contractions, orthostatic hypotension, decreased blood pressure, increased blood pressure, rash, eczema, urticaria, pruritus, intraoperative pupillary dilation syndrome, blurred vision, eye congestion, eye itching, conjunctival hemorrhage, increased total bilirubin, increased Al-P, increased LDH, increased BUN, increased creatinine, decreased white blood cell count, decreased red blood cell count, decreased hemoglobin, decreased hematocrit, increased white blood cell count, decreased platelet count, facial swelling, tongue swelling, pharyngeal edema, gynecomastia, increased total cholesterol, elevated urine glucose, urinary sediment, facial flushing, tinnitus, bitter taste, chest pain, low back pain, lower limb fatigue, sweating, flushing, increased serum potassium level, decreased total protein, increased prostate-specific antigen, increased uric acid, increased urine protein, nasopharyngitis, urinary tract infection, urination disorders, excessive sedation, decreased orgasm, leg numbness, palpitations, itching, visual disturbances, decreased platelet count, fever, chills, lower limb fatigue, chest discomfort, low back pain, shoulder pain, increased blood uric acid, increased blood creatinine, increased urinary frequency, worsening dry mouth, hematuria, shingles

This medication may be sensitive to light and should be stored in a light-protective container. Additionally, to ensure safe use, it is important to store it at room temperature, between 1 to 30 degrees Celsius.

Appearance

White circular film-coated tablet

Package unit

60 tablets (10 tablets/PTP x 6)